Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research.

Stork C, Renshaw PF.

Mol Psychiatry. 2005 Oct;10(10):900-19. Review.

PMID:
16027739
2.

[Magnetic resonance spectroscopy (MRS) applications in bipolar disorder].

Monkul ES, Yildiz A, C Soares J.

Turk Psikiyatri Derg. 2004 Summer;15(2):138-47. Review. Turkish.

3.

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.

Yildiz-Yesiloglu A, Ankerst DP.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):969-95. Epub 2006 May 4. Review. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):591.

PMID:
16677749
4.

Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings.

Silverstone PH, McGrath BM, Kim H.

Bipolar Disord. 2005 Feb;7(1):1-10. Review.

PMID:
15654927
5.

Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders.

Soares JC, Krishnan KR, Keshavan MS.

Depression. 1996;4(1):14-30. Review.

PMID:
9160650
6.

Mitochondrial dysfunction in bipolar disorder.

Kato T, Kato N.

Bipolar Disord. 2000 Sep;2(3 Pt 1):180-90. Review.

PMID:
11256685
7.

Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease.

Henchcliffe C, Shungu DC, Mao X, Huang C, Nirenberg MJ, Jenkins BG, Beal MF.

Ann N Y Acad Sci. 2008 Dec;1147:206-20. doi: 10.1196/annals.1427.037. Review.

PMID:
19076443
8.

[Magnetic resonance spectroscopy in schizophrenia].

Delamillieure P, Constans JM, Fernandez J, Dollfus S.

Encephale. 2000 Jan-Feb;26(1):21-31. Review. French.

PMID:
10875059
9.

[Predictors of prophylactic response to lithium].

Rohayem J, Baylé JF, Richa S.

Encephale. 2008 Sep;34(4):394-9. doi: 10.1016/j.encep.2007.05.002. Epub 2007 Nov 26. Review. French.

PMID:
18922242
10.

[Mitochondrial dysfunction in bipolar disorder].

Kato T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2005 Apr;25(2):61-72. Review. Japanese.

PMID:
16220655
11.

Neurochemical predictors of response to pharmacologic treatments for bipolar disorder.

Delbello MP, Strakowski SM.

Curr Psychiatry Rep. 2004 Dec;6(6):466-72. Review.

PMID:
15538996
12.

[Contribution of magnetic resonance spectroscopy in predicting severity and outcome in traumatic brain injury].

Payen JF, Francony G, Fauvage B, Le Bas JF.

Ann Fr Anesth Reanim. 2005 May;24(5):522-7. Epub 2005 Apr 20. Review. French.

PMID:
15904731
14.

Mitochondrial dysfunction and psychiatric disorders.

Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL.

Neurochem Res. 2009 Jun;34(6):1021-9. doi: 10.1007/s11064-008-9865-8. Epub 2008 Nov 1. Review.

PMID:
18979198
15.

The role of mitochondrial dysfunction in bipolar disorder.

Kato T.

Drug News Perspect. 2006 Dec;19(10):597-602. Review.

PMID:
17299601
16.

[Application of magnetic resonance spectroscopy in the study of brain disease].

Pérez-Gómez M, Junqué C, Mercader JM, Berenguer J.

Rev Neurol. 2000 Jan 16-31;30(2):155-60. Review. Spanish.

PMID:
10730323
17.
18.

Review of magnetic resonance imaging and spectroscopy studies in children with bipolar disorder.

Adleman NE, Barnea-Goraly N, Chang KD.

Expert Rev Neurother. 2004 Jan;4(1):69-77. Review.

PMID:
15853617
20.

Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.

Reddy R, Keshavan MS.

Prostaglandins Leukot Essent Fatty Acids. 2003 Dec;69(6):401-5. Review.

PMID:
14623493

Supplemental Content

Support Center